diaTribe

Wearables such as smartwatches are often used to monitor glucose at a glance. But by tracking physical activity, sleep quality, signs of stress, and other measures, they can monitor and encourage habits that can help improve diabetes management and overall health. The American Diabetes Association recommends getting 150 minutes or more of moderate physical activity a week.

Let me guess how you got here. You asked Google or a chatbot something like “Should I take Ozempic?” or “Mounjaro side effects.” You got a competent answer. It explained what GLP-1 medications are, listed the side effects, told you to talk to your doctor, and left you exactly where you started: alone with the actual decision. If you want to know what comes after the definition, this article is for you. I am not going to explain what a gut hormone is for six paragraphs.

Type 1 diabetes screening can provide time to prepare, find specialist care, and potentially seek treatment to delay its progression. But the topic is a personal one for parents who have type 1 and may raise difficult questions. A recent diaTribe webinar brought together experts and people with type 1 diabetes to share their experiences and stories about using screening to help avoid a diagnosis made during an emergency.

You're taking your medications, watching your carbs, getting your steps in, and yet your A1C still won't decrease. One underappreciated reason may be cortisol. Hypercortisolism, or the prolonged elevation of the stress hormone cortisol, can raise glucose levels and make it hard for people with type 2 diabetes to hit their A1C and time in range targets even if they are taking medication, exercising, and eating a healthy diet.

Trial Status: Recruiting Clinical Trials Identifier: NCT07282600 Trial Name: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes (ENLIGHTEN-2) Diabetes Type: Type 2 diabetes Trial Sponsor: Eli Lilly and Company Why is this study important? This study is testing the safety and efficacy of an experimental drug, eloralintide, for weight management in people with type 2 diabetes and overweight or obesity.

Type 1 diabetes screening typically requires a blood test. Geneticist Yuta Matsuda, founder of T1D Scout, developed an at-home test that starts with a saliva swab instead. If the test shows higher genetic risk, families can follow up with at-home antibody testing. Matsuda said the goal is to make screening easier to access and more likely to be completed – especially for families who may have trouble getting to a research site or completing a blood test with a young child.

GLP-1 receptor agonists like Ozempic and Mounjaro have reshaped the conversation around weight loss and diabetes management. Now, a growing number of people are experimenting with something even further outside the guidelines: taking these medications at a fraction of the approved dose. Microdosing, which means taking a medication at a dose smaller than the approved dose, is not FDA-approved, but has gained traction on social media, in wellness circles, and now, in clinical conversations.

This educational article was made possible with materials and support from Tandem Diabetes Care. Automated insulin delivery (AID) systems have been traditionally used by people with type 1 diabetes but are now more widely available for those with type 2 diabetes after the approval of several major systems in 2025, including the Tandem Diabetes Care t:slim X2 insulin pump and Tandem Mobi system with Control-IQ+ technology, the predictive algorithm with research-proven results.

Key takeaways: Many important molecules in the body are peptides. Some peptides, like GLP-1, can be modified into effective medications for a variety of conditions, including diabetes. Recently, health, wellness, and fitness influencers have been touting the benefits of unapproved peptides that are often sold “for research purposes only.” If a peptide has not been approved as a medication, then taking it can be risky and potentially ineffective.

People with diabetes sometimes hear comments from coworkers that can feel hurtful or judgmental. Routine care, like taking insulin or checking glucose, sometimes feels conspicuous, and coworkers' lack of understanding may leave people feeling like they're being judged, treated differently, or seen as less capable. Like others with diabetes, I've felt primarily acceptance and support from coworkers as I juggled type 1 along with my workload in half a dozen offices.